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In this study, we investigated the genome-wide gene expression profiles in the liver tissue of diabetic rats before
and after RS treatment. The microarray-based analysis revealed that a total of 173 genes were up-regulated and 197
genes were down-regulated in response to RS treatment. These genes were mainly related to glucose metabolism
(e.g., hexokinase, pyruvate kinase and phosphotransferase etc.), and lipid metabolism (e.g., carnitine palmitoyl
transfer 1, fatty acid transporter, beta hydroxyl butyric dehydrogenase etc.). Cluster analysis results showed that
the up/down-regulated genes were highly responsive to RS treatment, and were considered to be directly or
indirectly associated with reducing plasma glucose and body fat. To interpret the mechanism of RS regulation at
the molecular level, a novel gene network was constructed based on 370 up/down-regulated genes coupled
with 718 known diabetes-related genes. The topology of the network showed the characteristics of small-world
and scale-free network, with some pathways demonstrating a high degree. Forkhead class A signaling pathway,
with a degree of 8, was analyzed and was found to have an effect mainly on glucose and lipid metabolism processes.
The results indicate that RS can suppress the development of type 2 diabetes in the STZ rat model through modulating
the expression of multiple genes involved in glucose and lipid metabolism. The potential application of this novel gene
network is also discussed.
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Starch is the most abundant storage glucan composed of
two main structural components, amylose and amylo-
pectin. Based on the rate of digestion, starch can be
classified as rapidly digestible starch (RDS), slowly di-
gestible starch (SDS), and resistant starch (RS) (Shi and
Maningat 2013). In recent years, the effect of RS has
drawn increasing interests in that it is not digested in
the upper gastrointestinal tract, but is fermented in the
large intestine and is beneficial for the gut environment
(Lafiandra et al. 2014). Our recent research has shown
that the applications of RS in foods can moderate the
glycemic response and maintain a proper microorgan-
ism profile in the human gut (Zhou et al. 2013a, b). It* Correspondence: zkzhou@tust.edu.cn
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in any medium, provided the original work is phas also been found that RS with a slow absorption and
a low glycemic index can reduce blood lipids and im-
prove insulin sensitivity, which can improve the glucose
intolerance and insulin resistance (Goda et al. 2014).
Previous studies have also shown that RS can reduce
cholesterol and triglyceride levels in liver and serum of
type 2 diabetic rats (Britto et al. 2004).
Diabetes affects approximately 8% of the United States
population and 23% of the population >60 y of age,
manifested predominantly as type 2 diabetes (von der
Schulenburg and Frank 2014) and treatment for diabetes
is relatively limited with significant side effects. Previous
reports have indicated that lifestyle modifications, such
as increasing fasting and exercise may reduce some risk
factors such as postprandial glucose levels, decreased in-
sulin sensitivity and obesity, which are more effective
than pharmacological intervention in delaying the onset
of type 2 diabetes (Stanhope et al. 2009). The discovery
of natural products with health benefits as an alternativen Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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sive research has become many people’s interest. To
investigate the contributing role of RS in maintaining
normal plasma glucose and body fat levels, we have
used a rat model of type 2 diabetes mellitus as a patho-
logical model.
Analysis of gene expression variation in the liver,
the site of lipid degradation and glycogen storage, is
a widely used approach to understand blood glucose
and body fat level changes (Kodama et al. 2012). To
discover new genes or new molecular networks
involved in the diabetes pathogenesis, microarray
technology currently offers the fastest and most com-
prehensive molecular evaluation (Dillies et al. 2013)
and many studies have applied microarrays to under-
stand gene expression profiles in Diabetes Mellitus
(Lowe et al. 2007; del Rosario et al. 2014). However,
limited reports have described that functional foods
or materials directly modulated gene expression pro-
files of diabetes-relevant organs (Park et al. 2012).
Thus, in this study, genome-wide analyses are per-
formed in liver tissues of STZ-induced diabetic rats




RS, from high amylose maize (Hi-maize™), was obtained
from National Starch and Chemical Company, NSW,
Australia. Streptozotocin (STZ) was purchased from
Sigma-Aldrich (St. Louis, MO, USA). Other chemicals
were of reagent grade and used as received.
Animals and diets
Healthy male Sprague–Dawley rats (non-diabetic) of
190 ± 10 g weight were purchased from the animal
house, Chinese Military Medical Science Academy. 16
rats were divided into two groups randomly: model con-
trol and RS interventional group. SD rats were housed
in plastic cages (4 rats/cage) with free access to food and
water, under controlled conditions of humidity (55 ±
5%), light (12/12 h light/dark cycle) and temperature (at
23°C). After one week’s adaptive feeding with the basic
diet, the rats were fasted for 12 h, followed by intraven-
ous injection of STZ 45 mg/ kg except the rats in nor-
mal control group. After 72 h of the injection, theTable 1 Change in the body weights of type 2 diabetic rats fo
Body weights (g)
Group Initial weight 72 h 1 week
Model control 204.60 ± 7.83 201.20 ± 9.42 202.60 ±
RS treatment 201.80 ± 6.75 201.00 ± 7.32 203.00 ±
Results were expressed as means ± SD (n = 8, one-way ANOVA). There was no significafasting blood glucose (FBG) levels were estimated using
a glucometer (ACCU-CHEK, ROCHE). Rats with FBG
levels higher than 16.7 mmol/L were considered dia-
betic and were included insubsequent experiments.
Normal control and model control continued with the
basal diet for 4 weeks. RS was administered for the
interventional group by oral gavage, using a feeding
needle with 2 g once daily (which was about 8% of the
total diet) for 4 consecutive weeks before the animals
were sacrificed. There were no obvious signs of toxicity
throughout the course of the experiments and all
treated animals survived. The basal diet contained 7%
fat, 13% protein, and a highly digestible starch. During
the experimental course of the 4 weeks, blood samples
were collected from the tail vein and body weights were
recorded weekly (Table 1). Experimental procedures
were approved by the Animal Ethics Committee of
PLA Military Science and complied with the Chinese
Code of Practice for the Care and Use of Animals for
Scientific Purposes.
Biological analysis
At the end of the experimental feeding period (4 weeks),
blood samples were collected from the femoral artery
after sacrifice and stored at −80°C prior to chemical ana-
lyses. Blood lipid composition including high-density
lipoprotein-cholesterol (HDL-c), total cholesterol (TCH)
and triglyceride (TG), were measured according to the
kit instructions (Jiancheng Biological Engineering
Institute, Nanjing, China).
After the 4-weeks feeding, the rats were dissected im-
mediately with sterile scissors. The livers were sampled,
weighed and immediately placed in liquid nitrogen until
frozen thoroughly. All the liver samples were then stored
at −80°C until RNA extraction.
Microarray design
Liver tissue was removed from storage and homoge-
nized. The total RNA was extracted using the Trizol
reagent (Takara) and then treated with RNase-free
DNase to remove contaminating genomic DNA. The
quality and integrity of RNA was assessed using agarose
gel electrophoresis. The microarray analysis of samples
for RS (for RS treatment) and CK (for comparison) was
performed by the Bioassay Laboratory of CapitalBio
Corporation using the Rat Genome 230 2.0 Arrayllowing the RS treatment
2 weeks 3 weeks 4 weeks
9.32 181.20 ± 14.25 216.20 ± 13.07 204.60 ± 18.24
9.06 195.20 ± 8.52 213.30 ± 8.10 213.80 ± 9.92
nt difference in the body weights of the diabetic rats between the two groups.
Figure 1 Cluster analysis of genes before (CK) and after RS treatment.
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trol signals such as Oligo B2, Poly-A Controls and
Hybridization Controls were all normal. The house-
keeping gene signals and the ratio of 3′ on 5′ also
remained normal with low average background values
and noise values.Comparison analysis
The image signal data were first stored as a . DAT file,
and then transformed to digital signal data as a .CEL file
using AGCC software (Affymetrix Gene Chip Command
Console Software). The fluorescence signal intensity
levels were pre-analyzed using the RMA algorithm
Table 2 Diabetes-associated genes up/down-regulated in the liver of diabetic rats after RS treatments
Gene symbol Gene name Ratio
Cpt1a carnitine palmitoyltransferase 1a, liver 2.2353
G6pc glucose-6-phosphatase, catalytic subunit 2.3547
Txnip thioredoxin interacting protein 2.1232
Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase 2.0119
Src SRC proto-oncogene, non-receptor tyrosine kinase 2.102
Pfas Phosphoribosylformylglycinamidine synthase 2.524
Ppargc1b peroxisome proliferator-activated receptor gamma, coactivator 1 beta 2.6752
Ccl2 chemokine (C-C motif) ligand 2 0.3036
Serpina7 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin),member 7 0.3717
Fga fibrinogen alpha chain 0.3675
Pik3c2a phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha 0.452
Isg15 ISG15 ubiquitin-like modifier 0.2822
Gck glucokinase 0.3975
Casp12 caspase 12 0.4165
Cxcl10 chemokine (C-X-C motif) ligand 10 0.4329
Apln apelin 0.4918
Kng1 kininogen 1 0.4918
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analysis: 3 or more biological replications were per-
formed and analyzed, using the R language package
based on SAM (significance analysis of microarray) to
analyze the differential gene expression, the screening
standard was: Q-value ≤ 5% and the Fold Change ≥ 2
or ≤ 0.5.
Statistical analysis
The results were analyzed for statistical significance by
one-way analysis of variance (ANOVA) test using the
Statistical Package of the Social Science (SPSS)
program. All data are expressed as mean ± SD values.
In all analyses, a P < 0.05 was considered statistically
significant.
Results and discussion
Gene expression profile in the liver tissues of diabetic rats
Prior to the gene expression study, the effect of RS on
plasma glucose and body fat levels was determined in
STZ-induced diabetic rats. Our previous results re-
vealed that rats treated with RS for two-week’s showed
a 15.9% reduction in blood glucose levels compared to
its initial level, and there was a total 27.9% reduction in
the blood glucose level after 4-weeks treatment of RS,
resulting in a significant difference compared to the
model control group (P < 0.001) (data submitted for
publication).
Gene expression profiling was carried out using the
rat genome 230 2.0 array (Affymetrix Cooperation) in
liver tissues of STZ-induced and RS-treated STZ-induced diabetic rats. Hierarchical clustering was used
to globally assess the function-dependent gene ex-
pression patterns and initial interpretation of the
extensive data set, and in particular, to identify corre-
lated expression patterns that reflect the biological
processes occurring in the pancreatic tissues. As
shown in Figure 1, clustering display highlights the
differential expression of numerous genes (up- or
down regulated) among the groups. Among the
31,041 total genes, exactly 370 were counted as dif-
ferentially expressed genes (ratio > 2 or <0.5) in the
rat livers. Among them, 173 genes were up-regulated
by RS treatment, and 197 genes were down-regulated.
These results suggest that liver-specific gene expres-
sion is responsive to RS treatment, and this expres-
sion pattern could be considered to be directly or
indirectly associated with reducing blood glucose and
body fat activity.Local gene network and topology analysis
To interpret the effect of RS on diabetic physiological
indices, specific genes associated with diabetes were
analyzed using the Rat Genome Database (Simon et al.
2007). The significantly regulated diabetes-associated
genes from the rat genome database were presented in
Table 2. A total of 17 genes were observed to be differ-
entially expressed in the liver in the RS treatment
group compared with STZ-induced diabetic rats
without treatment. Specifically, this included 7 up-
regulated genes (Cpt1a, G6pc, Txnip, Hmgcr, Src, Pfas,
Figure 2 Local gene networks (LGN) of diabetes-associated up/down-regulated genes connected by indicated pathways. The genes
with red base were up-regulated in response to RS treatment, while those with a green base were down-regulated. Other highlighted genes were
diabetes-associated genes which participated in the pathways.
Table 3 Glucose metabolism-related genes in the LGN
Gene symbol Gene name
Phka1 phosphorylase kinase, alpha 1
Hk2 hexokinase 2
Gckr glucokinase (hexokinase 4) regulator
Gck glucokinase
Aldob aldolase B, fructose-bisphosphate
G6pc glucose-6-phosphatase, catalytic subunit
Pygm phosphorylase, glycogen, muscle
Ppp1r3a protein phosphatase 1, regulatory subunit 3A
Gapdh glyceraldehyde-3-phosphate dehydrogenase
Akr1b1 aldo-keto reductase family 1, member B1 (aldose reductase)
Pklr pyruvate kinase, liver and RBC
Eno2 enolase 2, gamma, neuronal
Pck1 phosphoenolpyruvate carboxykinase 1 (soluble)
The genes were sequenced in the order they appeared in the metabolism process.
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Serpina7, Fga, Pik3c2a, Isg15, Gck, Casp12, Cxcl10,
Apln, Kng1).
The diabetes-associated genes that participate in the
same biological pathways as those differentially
expressed by RS treatment were investigated simul-
taneously. These genes were collected and arranged,
and a Local Gene Network (LGN) was produced as
shown in Figure 2, where most pathways were con-
nected with diabetes-related genes that were differ-
ently expressed or not. The genes that were up/down
regulated were labeled with red/green base, respect-
ively. There were 38 pathways involved in the con-
nection of diabetes-related up/down regulated genes.
Among them, 31 pathways were included in a large
main network, while 7 other pathways were isolated
from the main network.
From a topological perspective where a gene is com-
monly reported participating in about 3 pathways, the
Figure 3 Ratio of the expression of the glycol-metabolism-related genes before and after RS treatment.
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However, some main pathways show larger degrees
than others, such as the R1-forkhead class A signaling
pathway has a degree of 8. As observed, the main net-
work showed the characteristics of a small-world net-
work, in terms of the average path length, some of
which very short with a value of 3.68. In addition, a
scale-free network feature was also clear and from the
hierarchical structures can be seen in several local mo-
tifs, overall the cluster coefficient of the main network
was 0.26.
Forkhead class A signaling is a core pathway in the
network
In the LGN (Figure 2), it is clearly demonstrated that
R1-forkhead class A signaling pathway is connected
with 8 pathways (R2-eicosanoid signaling pathway, R3-
fatty acid beta degradation pathway, R5-gluconeogenesis
pathway, R8-cholesterol biosynthetic pathway, R17-
vascular endothelial growth factor signaling pathway,














The genes were sequenced in the order they appeared in the metabolism process.R30-amyotrophic lateral sclerosis disease pathway).
These pathways are connected directly with the main
glucose metabolism and lipid metabolism processes.
Forkhead family, a group of conserved transcription
factors in both yeast and human, is distinguished by
the presence of a 100aa forkhead DNA binding domain.
Forkhead transcription factors play important roles in
regulating a number of cell processes including devel-
opment, cell proliferation and differentiation, mainten-
ance of stemness, stress response, language acquirement,
and longevity (Tuteja and Kaestner 2007). Among the
genes described in this pathway, Igfbp1 and Hnf4a also
present in the hypoxia inducible factor HIF-1 pathway
(Steuerwald et al. 2010). HIF-1-regulated target genes in-
clude erythropoietin (EPO), vascular endothelial growth
factor (VEGF), insulin-like growth factor II (IGF-2) and ex-
amples of glycolytic enzymes (aldolase A, enolase 1, 1actate
dehedrogenase A, phosphofructokinase L, phosphoglycer-
ate kinase1, glyceraldehydes-3-phosphate dehydrogenase,
etc.). The Hadh gene regulates 3-hydroxyacyl-CoA
dehydrogenase (Kapoor et al. 2009), and is reported mainlyGene name
potassium inwardly rectifying channel, subfamily J, member 11
hepatocyte nuclear factor 4, alpha
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)
carnitine palmitoyltransferase 1a, liver
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial)
3-hydroxy-3-methylglutaryl-CoA reductase
3-hydroxybutyrate dehydrogenase, type 1
acetyl-CoA acyltransferase 1
adiponectin, C1Q and collagen domain containin
peroxisome proliferator-activated receptor gamma
peroxisome proliferator-activated receptor delta
acyl-CoA synthetase long-chain family member 6
Figure 4 Ratio of the expression of the lipid metabolism-related genes before and after RS treatment.
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the 3rd process of β-oxidation. These results may indicate
that this pathway could be regulated by glucose and lipid
metabolism in response to RS treatment.Glucose and lipid metabolism modules analysis
From these results a close relationship between the
forkhead class A signaling pathway and glucose and
lipid metabolism could be observed (Figure 2). 13
genes related to glucose metabolism in the LGN were
sequenced by the order they appeared in the metabol-
ism process (Table 3), and two genes were differently
expressed in response to RS treatment. The ratios of
the expression of the glucose metabolism-related
genes after and before RS treatment were shown in
Figure 3. The majority of the glucose metabolism-
related genes were shown to be up-regulated with RS
treatment (Ratio > 1), indicating that the glucose
metabolism process becomes more active with the
addition of RS, which may result in a decrease in
blood glucose levels. Conversely, down-regulated
genes did not express key enzymes included in glu-
cose metabolism. More specifically, the genes related
to glycolysis were up-regulated in varying degrees
(Hk2, Pklr, Gapdh, etc.). The genes which were down-
regulated, such as Gck, were not involved in glyco-
lytic process.
Using a similar approach, the 12 genes related to
lipid metabolism in the LGN were sequenced accord-
ing to the order they appeared in the metabolism
process (Table 4), and two genes were over-expressed
in response to RS treatment. The ratio of expression
of the lipid metabolism-related genes after and before
RS treatment was shown in Figure 4. Similar to the
results associated with glucose metabolism, most of
the lipid metabolism-related genes were up-regulated
with RS treatment (Ratio > 1), which also indicated
that the lipid metabolism processes may becomemore active with the addition of RS, which may result
in a decrease in body fat.
In this study, we have proposed a novel gene net-
work based on a comparative genome-wide analysis
and used a knowledge-based gene assembly to
analyze the possible molecular mechanisms of the RS
effect. Some pathways were not connected to the
main network possibly because not all diabetes-
related genes have been well reported. As a high-
throughput method, microarray technology may be
not fully accurate in that not all target sites were accur-
ately tested. In this study, a genome-wide analysis was
performed where the main characteristics of the net-
work could be universal. In terms of the network top-
ology, alterations with glucose and lipid metabolism
networks were consistent with the proposed effects of
RS as a dietary intervention, suggesting that this analyt-
ical method using a recombination-based network
could be used for the analysis of similar substances.
However, further work is needed to clarify the molecu-
lar mechanisms of RS in reducing the levels of plasma
glucose and body fat.
Conclusion
In this study, we demonstrate that RS may provide dir-
ect signals to rat liver cells and regulate the expression
of a number of diverse genes, suggesting that RS may
modulate its effect through a network involving com-
plex gene regulatory events. These altered levels of
gene expression in response to RS treatment may indi-
cate that the candidate genes and their surrounding
network partners could contribute to the array of com-
plications in the diabetic mammals. Importantly, we
show that the bioinformatics analysis is a feasible and
powerful approach to interpret the underlying molecu-
lar mechanism of RS. Further study is required to fur-
ther elucidate the pathways affected by RS treatment
and this will be further enhanced by increased annota-
tion of the rat genome.
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